RELL2

gene
On this page

Also known as FLJ90583

Summary

RELL2 (RELT like 2, HGNC:26902) is a protein-coding gene on chromosome 5q31.3, encoding RELT-like protein 2 (Q8NC24). Induces activation of MAPK14/p38 cascade, when overexpressed.

Predicted to enable collagen binding activity. Involved in positive regulation of p38MAPK cascade. Predicted to be located in basement membrane and plasma membrane.

Source: NCBI Gene 285613 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 8 total
  • MANE Select transcript: NM_173828

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26902
Approved symbolRELL2
NameRELT like 2
Location5q31.3
Locus typegene with protein product
StatusApproved
AliasesFLJ90583
Ensembl geneENSG00000164620
Ensembl biotypeprotein_coding
OMIM611213
Entrez285613

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 5 protein_coding, 3 protein_coding_CDS_not_defined

ENST00000297164, ENST00000444782, ENST00000517794, ENST00000518025, ENST00000518856, ENST00000520674, ENST00000521367, ENST00000896721

RefSeq mRNA: 2 — MANE Select: NM_173828 NM_001130029, NM_173828

CCDS: CCDS4265

Canonical transcript exons

ENST00000297164 — 7 exons

ExonStartEnd
ENSE00001160506141636997141638409
ENSE00002104435141640671141641064
ENSE00003460119141638955141639021
ENSE00003514338141640412141640445
ENSE00003544561141638795141638860
ENSE00003676392141639920141640295
ENSE00003681668141639464141639649

Expression profiles

Bgee: expression breadth ubiquitous, 183 present calls, max score 92.00.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.8266 / max 162.4997, expressed in 1643 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
590505.35711563
590512.3565859
590490.112940

Top tissues by expression

241 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right frontal lobeUBERON:000281092.00gold quality
lateral nuclear group of thalamusUBERON:000273691.69gold quality
prefrontal cortexUBERON:000045190.35gold quality
right hemisphere of cerebellumUBERON:001489090.27gold quality
Brodmann (1909) area 9UBERON:001354089.67gold quality
anterior cingulate cortexUBERON:000983588.46gold quality
cerebellar cortexUBERON:000212988.43gold quality
cerebellar hemisphereUBERON:000224588.43gold quality
dorsolateral prefrontal cortexUBERON:000983488.17gold quality
frontal cortexUBERON:000187088.15gold quality
hypothalamusUBERON:000189888.12gold quality
neocortexUBERON:000195087.39gold quality
cerebellumUBERON:000203787.22gold quality
adenohypophysisUBERON:000219686.64gold quality
pituitary glandUBERON:000000786.47gold quality
granulocyteCL:000009485.68gold quality
nucleus accumbensUBERON:000188285.59gold quality
cerebral cortexUBERON:000095684.72gold quality
primary visual cortexUBERON:000243684.65gold quality
substantia nigraUBERON:000203884.32gold quality
putamenUBERON:000187484.01gold quality
forebrainUBERON:000189083.92gold quality
brainUBERON:000095583.85gold quality
caudate nucleusUBERON:000187383.74gold quality
midbrainUBERON:000189182.70gold quality
ponsUBERON:000098882.06gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.79silver quality
occipital lobeUBERON:000202181.40gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099181.36gold quality
cortical plateUBERON:000534380.99gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-7303no423.53
E-ANND-3no1.20

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

27 targeting RELL2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-211099.9666.681930
HSA-MIR-6753-3P99.9366.57637
HSA-MIR-7107-3P99.9366.73627
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-427199.8868.322244
HSA-MIR-3065-3P99.8770.251407
HSA-MIR-383-3P99.8565.841359
HSA-MIR-452799.6667.43714
HSA-MIR-6503-5P99.6266.96597
HSA-MIR-451699.6167.783390
HSA-MIR-1207-5P99.4969.112983
HSA-MIR-6722-3P99.4567.621919
HSA-MIR-4763-3P99.1067.832649
HSA-MIR-1909-3P99.0366.561662
HSA-MIR-423-5P98.6967.481522
HSA-MIR-3184-5P98.5667.131491
HSA-MIR-58198.3967.42835
HSA-MIR-6511B-5P97.9865.64823
HSA-MIR-6811-5P97.9864.96848
HSA-MIR-10526-3P97.8664.971342
HSA-MIR-286195.2465.471056
HSA-MIR-1250-5P94.3264.7478
HSA-MIR-6789-5P94.0566.19285

Literature-anchored findings (GeneRIF, showing 3)

  • Binds to the TNF receptor family member RELT; homologue of RELT. (PMID:16389068)
  • report that overexpression of RELT or its homologues RELL1 and RELL2 in HEK 293 epithelial cells results in cell death with morphological characteristics consistent with the activation of an apoptotic pathway. (PMID:19969290)
  • Comprehensive Analysis of RELL2 as a Potential Biomarker Associated with Tumor Immune Infiltrating Cells in a Pan-Cancer Analysis. (PMID:35634441)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriorell2ENSDARG00000071876
mus_musculusRell2ENSMUSG00000044024
rattus_norvegicusRell2ENSRNOG00000019575

Protein

Protein identifiers

RELT-like protein 2Q8NC24 (reviewed: Q8NC24)

All UniProt accessions (3): E5RFS6, E5RHA7, Q8NC24

UniProt curated annotations — full annotation on UniProt →

Function. Induces activation of MAPK14/p38 cascade, when overexpressed. Induces apoptosis, when overexpressed.

Subunit / interactions. Interacts with RELT, RELL1 and OXSR1. Interacts with PLSCR1. Interacts with TRAF2.

Subcellular location. Cell membrane.

Tissue specificity. Primarily expressed in spleen, thymus, testis, peripheral blood leukocytes, brain and placenta. Not detected in prostate, ovary, small intestine, colon, heart, lung, liver, skeletal muscle, kidney and pancreas.

Post-translational modifications. Phosphorylated in vitro by OXSR1.

Similarity. Belongs to the RELT family.

RefSeq proteins (2): NP_001123501, NP_776189* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR022248TNF_rcpt_RELTFamily
IPR042313RELL2Family

Pfam: PF12606

UniProt features (13 total): sequence variant 4, compositionally biased region 4, region of interest 2, chain 1, transmembrane region 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NC24-F160.010.08

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 52

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 79 (showing top): RNGTGGGC_UNKNOWN, AP1_01, AAGCAAT_MIR137, SP3_Q3, AREB6_03, GOBP_POSITIVE_REGULATION_OF_MAPK_CASCADE, TGACCTY_ERR1_Q2, GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION, AP1_Q4_01, BACH2_01, GOBP_POSITIVE_REGULATION_OF_P38MAPK_CASCADE, TGANTCA_AP1_C, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, GOBP_REGULATION_OF_CELL_SUBSTRATE_ADHESION, GATA2_01

GO Biological Process (2): positive regulation of cell-substrate adhesion (GO:0010811), positive regulation of p38MAPK cascade (GO:1900745)

GO Molecular Function (2): collagen binding (GO:0005518), protein binding (GO:0005515)

GO Cellular Component (4): basement membrane (GO:0005604), plasma membrane (GO:0005886), membrane (GO:0016020), extracellular matrix (GO:0031012)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of cell-substrate adhesion1
cell-substrate adhesion1
positive regulation of cell adhesion1
p38MAPK cascade1
positive regulation of MAPK cascade1
regulation of p38MAPK cascade1
protein-containing complex binding1
binding1
extracellular matrix1
membrane1
cell periphery1
cellular anatomical structure1
external encapsulating structure1

Protein interactions and networks

STRING

248 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RELL2OXSR1O95747856
RELL2CCDC15Q0P6D6528
RELL2TRAF1Q13077506
RELL2FCHSD1Q86WN1447
RELL2M1APQ8TC57392
RELL2XKR6Q5GH73370
RELL2ZDHHC16Q969W1365
RELL2RELTQ969Z4362
RELL2CCHCR1Q8TD31351
RELL2PCDHGA6Q9Y5G7314
RELL2AKAP11Q9UKA4311
RELL2STK39Q9UEW8301
RELL2RELL1Q8IUW5298
RELL2PCDHGB6Q9Y5F9284
RELL2SRSF4Q08170250
RELL2SPZ1Q9BXG8250

IntAct

69 interactions, top by confidence:

ABTypeScore
OXSR1RELL2psi-mi:“MI:0915”(physical association)0.830
RELL2OXSR1psi-mi:“MI:0915”(physical association)0.830
RELL2OXSR1psi-mi:“MI:0914”(association)0.830
ZNF32RELL2psi-mi:“MI:0915”(physical association)0.590
PLP1RELL2psi-mi:“MI:0915”(physical association)0.560
ANKRD46RELL2psi-mi:“MI:0915”(physical association)0.560
SLC35A1RELL2psi-mi:“MI:0915”(physical association)0.560
SEC22BRELL2psi-mi:“MI:0915”(physical association)0.560
SLC30A8RELL2psi-mi:“MI:0915”(physical association)0.560
COL4A5RELL2psi-mi:“MI:0915”(physical association)0.560
ASPHRELL2psi-mi:“MI:0915”(physical association)0.560
TSPO2RELL2psi-mi:“MI:0915”(physical association)0.560
NSG1RELL2psi-mi:“MI:0915”(physical association)0.560
RELL2LPAR3psi-mi:“MI:0915”(physical association)0.560
RTP2RELL2psi-mi:“MI:0915”(physical association)0.560
TSPAN33RELL2psi-mi:“MI:0915”(physical association)0.560
RELL2CLDND2psi-mi:“MI:0915”(physical association)0.560
CDIPTRELL2psi-mi:“MI:0915”(physical association)0.560
ZFPL1RELL2psi-mi:“MI:0915”(physical association)0.560
MIPRELL2psi-mi:“MI:0915”(physical association)0.560
TFRCRELL2psi-mi:“MI:0915”(physical association)0.560
RELL2FAM3Cpsi-mi:“MI:0915”(physical association)0.560
SMIM1RELL2psi-mi:“MI:0915”(physical association)0.560
RELL2ATP9Apsi-mi:“MI:0914”(association)0.350

BioGRID (68): RELL2 (Two-hybrid), TRIM9 (Affinity Capture-MS), OXSR1 (Affinity Capture-MS), LRR1 (Affinity Capture-MS), STK39 (Affinity Capture-MS), RELT (Affinity Capture-MS), AGBL5 (Affinity Capture-MS), MCM10 (Affinity Capture-MS), MGST2 (Affinity Capture-MS), HSPA14 (Affinity Capture-MS), DNAH14 (Affinity Capture-MS), SLC9A6 (Affinity Capture-MS), HADHB (Affinity Capture-MS), KIF2C (Affinity Capture-MS), C6orf120 (Affinity Capture-MS)

ESM2 similar proteins: A0A1B0GW64, A0A5F4BST2, A0PJX4, A8MVS5, A8MWV9, B0FP48, E5RIL1, E9PGG2, O14836, O60320, O95998, P09564, Q01113, Q01114, Q13477, Q2KI80, Q2T9R2, Q3TS39, Q3UPR0, Q3URD2, Q4V9L6, Q5FVJ4, Q5M869, Q6A044, Q6UWJ8, Q75VT8, Q864V4, Q8BRJ3, Q8BX43, Q8C503, Q8IVY1, Q8K5A9, Q8N112, Q8NC24, Q8NDY8, Q8QZT4, Q8R138, Q969Z4, Q9BUF7, Q9CQM1

Diamond homologs: Q08DP3, Q2KI80, Q5F3A4, Q5FVJ4, Q8BRJ3, Q8BX43, Q8IUW5, Q8K2J7, Q8NC24, Q969Z4, Q9N092, O95407, Q9HAV5, Q9NS68, Q9JLL3, Q8BX35

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 22 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Transport of small molecules59.7×1e-02

Disease & clinical

Clinical variants and AI predictions

ClinVar

8 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance8
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1314 predictions. Top by Δscore:

VariantEffectΔscore
5:141638776:A:AGacceptor_gain1.0000
5:141638786:A:AGacceptor_gain1.0000
5:141638787:T:Gacceptor_gain1.0000
5:141638793:A:AGacceptor_gain1.0000
5:141638794:G:GAacceptor_gain1.0000
5:141638794:GCT:Gacceptor_gain1.0000
5:141638857:GAAG:Gdonor_gain1.0000
5:141638861:G:Cdonor_loss1.0000
5:141638861:G:GGdonor_gain1.0000
5:141638953:A:AGacceptor_gain1.0000
5:141638954:G:GAacceptor_gain1.0000
5:141638954:GC:Gacceptor_gain1.0000
5:141638954:GCC:Gacceptor_gain1.0000
5:141638954:GCCA:Gacceptor_gain1.0000
5:141638954:GCCAA:Gacceptor_gain1.0000
5:141639017:TCCAG:Tdonor_loss1.0000
5:141639018:CCAG:Cdonor_loss1.0000
5:141639019:CAGGT:Cdonor_loss1.0000
5:141639020:AGGTG:Adonor_loss1.0000
5:141639022:GTGAG:Gdonor_loss1.0000
5:141639023:T:Adonor_loss1.0000
5:141639623:G:Tdonor_gain1.0000
5:141638405:GCCCC:Gdonor_gain0.9900
5:141638410:G:GGdonor_gain0.9900
5:141638414:G:GGdonor_gain0.9900
5:141638777:A:Gacceptor_gain0.9900
5:141638790:TTCA:Tacceptor_loss0.9900
5:141638791:TCAG:Tacceptor_loss0.9900
5:141638792:CAG:Cacceptor_loss0.9900
5:141638793:A:Cacceptor_loss0.9900

AlphaMissense

1978 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:141638846:T:AI79N1.000
5:141638846:T:CI79T1.000
5:141638846:T:GI79S1.000
5:141639921:T:CF169L1.000
5:141639922:T:CF169S1.000
5:141639922:T:GF169C1.000
5:141639923:C:AF169L1.000
5:141639923:C:GF169L1.000
5:141638298:T:CF25L0.999
5:141638300:C:AF25L0.999
5:141638300:C:GF25L0.999
5:141638310:G:CG29R0.999
5:141638319:G:CG32R0.999
5:141638320:G:AG32D0.999
5:141638331:T:CC36R0.999
5:141638332:G:AC36Y0.999
5:141638341:T:AL39H0.999
5:141638834:T:CI75T0.999
5:141638834:T:GI75S0.999
5:141638837:T:AV76D0.999
5:141638855:A:TN82I0.999
5:141638959:T:AN85K0.999
5:141638959:T:GN85K0.999
5:141638970:T:CL89S0.999
5:141638979:T:CM92T0.999
5:141639637:T:CF164S0.999
5:141639646:G:TG167V0.999
5:141639649:G:TR168M0.999
5:141639921:T:AF169I0.999
5:141639921:T:GF169V0.999

dbSNP variants (sampled 300 via entrez): RS1000405355 (5:141635653 TCAACTCAGG>T), RS1000738666 (5:141635114 G>A,C,T), RS1001189800 (5:141635758 C>T), RS1001569293 (5:141636124 C>T), RS1001725897 (5:141640771 G>A), RS1002461059 (5:141639398 C>A,T), RS1003058177 (5:141637411 C>T), RS1003125029 (5:141638426 G>A), RS1003727280 (5:141637685 T>G), RS1003949336 (5:141640457 T>C,G), RS1004085355 (5:141640764 A>C,G), RS1004905288 (5:141637331 C>A,T), RS1005119858 (5:141636209 A>G), RS1005501041 (5:141635703 C>G), RS1006540758 (5:141637344 G>A)

Disease associations

OMIM: gene MIM:611213 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST010002_39Refractive error2.000000e-14

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases abundance, increases expression2
tris(2-butoxyethyl) phosphateaffects expression1
beta-lapachonedecreases expression1
di-n-butylphosphoric acidaffects expression1
abrineincreases expression1
licochalcone Bincreases expression1
jinfukangincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Arsenicincreases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Cisplatindecreases expression1
Plant Extractsdecreases expression, affects cotreatment1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Triclosanincreases expression1
Urethanedecreases expression1
Valproic Acidincreases expression1
Cadmium Chlorideincreases expression1
Okadaic Acidincreases expression1
Acrylamidedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.